TruSight Cardio Sequencing Kit

• Expertly defined genes selected in collaboration with the Imperial College of London
• 99% of the targeted regions covered at a depth of at least 20×*
• Cost to sequence is ~ $1 US per gene; fully supported on Illumina sequencing and informatics platforms

The TruSight Cardio Kit uses next-generation sequencing (NGS) to provide comprehensive coverage of 174 genes with known associations to 17 ICCs, including cardiomyopathies, arrhythmias, aortopathies, and more. Genes were expertly selected with researchers at the National Heart and Lung Institute at the Imperial College of London. Content includes genes known to be associated with hereditary heart disease and emerging genes found in the literature.¹